AXSMAxsome Therapeutics, Inc.
$168.44+45% 1Y
$168.44
$116.0152 weeks$255.17
Is the price fair?
What AXSM's price assumes
Axsome Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 15.7× revenue.
15.7
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 147
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 15.6
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 147
- EV / EBIToperating margin −24%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 15.6
- Market capitalisation
- $12.2B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.